Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 9, 2010, Pages 1558-1565

  Obi, Yoshitsugu ^a   Kimura, Tomonori ^a   Nagasawa, Yasuyuki ^a   Yamamoto, Ryohei ^a   Yasuda, Keiko ^b   Sasaki, Koichi ^b   Kitamura, Harumi ^a   Imai, Enyu ^a   Rakugi, Hiromi ^a   Isaka, Yoshitaka ^a   Hayashi, Terumasa ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Cardiology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; RENIN INHIBITOR;

AGE; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; RETROSPECTIVE STUDY; STROKE;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; REFERRAL AND CONSULTATION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957299224     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08061109     Document Type: Article

References (47)

1. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42: 1050-1065, 2003 (Pubitemid 37413751)
3. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174, 2004
4. Kaysen GA, Eiserich JP: The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol 15: 538-548, 2004
5. Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA: Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: The heart and soul study. J Am Soc Nephrol 14: 3233-3238, 2003 (Pubitemid 37509298)
6. Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13: 745-753, 2002 (Pubitemid 34183941)
7. Drey N, Roderick P, Mullee M, Rogerson M: A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 42: 677-684, 2003 (Pubitemid 37187367)
8. Shlipak MG, Stehman-Breen C, Vittinghoff E, Lin F, Varosy PD, Wenger NK, Furberg CD: Creatinine levels and cardiovascular events in women with heart disease: Do small changes matter? Am J Kidney Dis 43: 37-44, 2004 (Pubitemid 38049433)
9. Roderick PJ, Atkins RJ, Smeeth L, Mylne A, Nitsch DDM, Hubbard RB, Bulpitt C, Fletcher AE: CKD and mortality risk in older people: A community-based population study in the United Kingdom. Am J Kidney Dis 53: 950-960, 2009
10. Patel UD, Young EW, Ojo AO, Hayward RA: CKD progression and mortality among older patients with diabetes. Am J Kidney Dis 46: 406-414, 2005 (Pubitemid 41208175)
11. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
12. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16: 489-495, 2005
13. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004 (Pubitemid 38392981)
14. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J: International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17: 2275-2284, 2006 (Pubitemid 44141918)
15. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007 (Pubitemid 350074801)
16. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S: Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 13: 631-632, 2009
17. Nakamura K, Okamura T, Hayakawa T, Kadowaki T, Kita Y, Ohnishi H, Saitoh S, Sakata K, Okayama A, Ueshima H: Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circ J 70: 954-959, 2006 (Pubitemid 44161729)
18. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003 (Pubitemid 36043346)
19. John R, Webb M, Young A, Stevens PE: Unreferred chronic kidney disease: A longitudinal study. Am J Kidney Dis 43: 825-835, 2004 (Pubitemid 38529620)
20. St Peter WL, Schoolwerth AC, McGowan T, McClellan WM: Chronic kidney disease: Issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis 41: 903-924, 2003 (Pubitemid 36532125)
21. Imai E, Yamagata K, Iseki K, Iso H, Horio M, Mkino H, Hishida A, Matsuo S: Kidney disease screening program in Japan: History, outcome, and perspectives. Clin J Am Soc Nephrol 2: 1360-1366, 2007
22. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009
23. Gray R: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals Statistics: 1141-1154, 1988
24. Fine J, Gray R: A proportional hazards model for the subdistribution of a competing risk. J Am Statistical Assn 94: 496-497, 1999
25. Royston P, Sauerbrei W, Freiburg G: Multivariable modeling with cubic regression splines: A principled approach. Stata J 7: 45, 2007
26. Holm A: Construction of efficient nuclear event analysis programs using a simple dedicated language. IEEE Transactions Nucl Sci 26: 4569-4571, 1979
27. Royston P: Multiple imputation of missing values. Stata J 4: 227-241, 2004
28. Agarwal R, Bunaye Z, Bekele DM, Light RP: Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol 28: 569-575, 2008 (Pubitemid 351832443)
29. Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver ED, Woolard NF, High KP: Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 20: 1199-1209, 2009
30. Eckardt KU, Berns JS, Rocco MV, Kasiske BL: Definition and classification of CKD: The debate should be about patient prognosis-a position statement from KDOQI and KDIGO. Am J Kidney Dis 53: 915-920, 2009
31. Menon V, Wang X, Sarnak MJ, Hunsicker LH, Madero M, Beck GJ, Collins AJ, Kusek JW, Levey AS, Greene T: Long-term outcomes in nondiabetic chronic kidney disease. Kidney Int 73: 1310-1315, 2008 (Pubitemid 351693160)
32. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR: Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 20: 1069-1077, 2009
33. Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, Kasiske B, Hostetter T: Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the national kidney foundation and the us food and drug administration. Am J Kidney Dis 54: 205-226, 2009
34. Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S: Slower decline of glomerular filtration rate in the Japanese general population: A longitudinal 10-year follow-up study. Hypertens Res 31: 433-441, 2008 (Pubitemid 351597496)
35. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J: Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20: 1813-1821, 2009
36. Taal MW, Brenner BM: Renal risk scores: Progress and prospects. Kidney Int 73: 1216-1219, 2008
37. Iseki K, Ikemiya Y, Iseki C, Takishita S: Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63: 1468-1474, 2003 (Pubitemid 36350012)
38. Iseki K, Kinjo K, Iseki C, Takishita S: Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 44: 806-814, 2004 (Pubitemid 39445912)
39. Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD: Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 17: 1444-1452, 2006 (Pubitemid 43673426)
40. Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyren O, Fored CM: The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 46: 863-870, 2005 (Pubitemid 41505460)
41. Johnson ES, Thorp ML, Yang X, Charansonney OL, Smith DH: Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis 50: 559-565, 2007 (Pubitemid 47454549)
42. O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS: Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18: 2758-2765, 2007 (Pubitemid 47531203)
43. Conway B, Webster A, Ramsay G, Morgan N, Neary J, Whitworth C, Harty J: Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dialysis Transplant 24: 1930-1937, 2009
44. Levin A, Djurdjev O, Beaulieu M, Er L: Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 52: 661-671, 2008
45. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG: Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 113: 2713-2723, 2006 (Pubitemid 43947989)
46. The number of households and population of municipalities in Osaka prefecture, The 2005 Japanese National Population Census. 2005. Available at http://www.pref.osaka.jp/toukei2/kokucho05/chouchou/xlslist.html. Accessed December 10, 2009
47. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S: One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297: 1197-1206, 2007 (Pubitemid 46465728)